Strides FDA Wednesday, January 31, 2007 0.00 Neutral

FDA Approves OXYCODONE HYDROCHLORIDE — Strides Pharma Science Limited

Strides Pharma Science Limited announced the FDA approval of its oral Oxycodone Hydrochloride generic, a move anticipated to intensify competitive pricing and drive generic market share capture within the opioid management sector.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day